Human recombinant ENA 78/CXCL5 (from E. coli)

Supplier: Shenandoah Biotechnology

100-185-100UG 100-185-1MG 100-185-20UG 100-185-500UG 100-185-5UG
SHBT100-185-100UGEA 453 EUR
SHBT100-185-100UG SHBT100-185-1MG SHBT100-185-20UG SHBT100-185-500UG SHBT100-185-5UG
Human recombinant ENA 78/CXCL5 (from E. coli)
Proteins and Peptides

Epithelial-derived neutrophil-activating peptide 78 (ENA 78), also known as CXCL5, is a chemokine that recruits neutrophils, promotes angiogenesis.


  • Produced from genetically modified E. coli
  • Stimulates connective tissue remodelling
  • Monomeric protein, contains 74 amino acids


ENA 78 production is stimulated by interleukin 1 (IL-1) or tumor necrosis factor alpha (TNFα), and signals through the chemokine receptor CXCR2.


ENA 78, 5-78 aa is one of three naturally occurring ENA 78 variants in which the N-terminus has been truncated.


Delivery information: A Certificate of Analysis (COA) is supplied with each product shipped detailing purity, formulation, biological activity, endotoxin levels, reconstitution instructions and recommended storage conditions.


Caution: This product is for research use only and is not for use in humans.

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR